These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 3924669)

  • 1. The combination of follicle-stimulating hormone and human menopausal gonadotropin for the induction of multiple follicular maturation for in vitro fertilization.
    Muasher SJ; Garcia JE; Rosenwaks Z
    Fertil Steril; 1985 Jul; 44(1):62-9. PubMed ID: 3924669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of the ratio in follicle-stimulating hormone and luteinizing hormone in induction of multiple follicular growth.
    Bernardus RE; Jones GS; Acosta AA; Garcia JE; Liu HC; Jones DL; Rosenwaks Z
    Fertil Steril; 1985 Mar; 43(3):373-8. PubMed ID: 3920087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization.
    Garcia JE; Padilla SL; Bayati J; Baramki TA
    Fertil Steril; 1990 Feb; 53(2):302-5. PubMed ID: 2105247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
    Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
    Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of pure FSH alone or in combination for ovulation stimulation in in vitro fertilization.
    Acosta AA; Bernardus RE; Jones GE; Garcia J; Rosenwaks Z; Simonetti S; Veeck LL; Jones D
    Acta Eur Fertil; 1985; 16(2):81-99. PubMed ID: 3929523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.
    Westergaard LG; Erb K; Laursen S; Rasmussen PE; Rex S
    Hum Reprod; 1996 Jun; 11(6):1209-13. PubMed ID: 8671425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination.
    Mercan R; Mayer JF; Walker D; Jones S; Oehninger S; Toner JP; Muasher SJ
    Hum Reprod; 1997 Sep; 12(9):1886-9. PubMed ID: 9363700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian stimulation with pure follicle-stimulating hormone/human menopausal gonadotropin and improved laparoscopic aspiration needles influence the success of an in vitro fertilization program.
    Eisermann J; Yang V; Register K; Swank N; Strickler RC
    Fertil Steril; 1989 Jan; 51(1):112-6. PubMed ID: 2521323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled ovarian hyperstimulation for in vitro fertilization using buserelin and gonadotropin in patients with previous failed cycles.
    Loong EP; Tam PP; Chiu TT; Chan MY; Panesar NS; Lau J
    Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):297-300. PubMed ID: 2129187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of hMG and/or FSH for multiple follicle development.
    Rosenwaks Z; Muasher SJ; Acosta AA
    Clin Obstet Gynecol; 1986 Mar; 29(1):148-57. PubMed ID: 3082552
    [No Abstract]   [Full Text] [Related]  

  • 13. The association between preovulatory serum 17 beta-estradiol pattern and conception in human menopausal gonadotropin-human chorionic gonadotropin stimulation.
    Laufer N; DeCherney AH; Tarlatzis BC; Naftolin F
    Fertil Steril; 1986 Jul; 46(1):73-6. PubMed ID: 3087791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone profile and follicle development in ovarian stimulation treatment for in vitro fertilization. II. Prolactin, estradiol and progesterone profile].
    Sudik R; Fliess FR; Kunkel S
    Zentralbl Gynakol; 1989; 111(9):567-80. PubMed ID: 2500795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simplification of the method of in vitro fertilization: sonographic measurements of follicular diameter as the sole index of follicular maturity.
    Nilsson L; Wikland M; Hamberger L; Hillensjö T; Chari S; Sturm G; Daume E
    J In Vitro Fert Embryo Transf; 1985 Mar; 2(1):17-22. PubMed ID: 3926921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clomiphene citrate and hMG: an alternative stimulation protocol for selected failed in vitro fertilization patients.
    Benadiva CA; Davis O; Kligman I; Liu HC; Rosenwaks Z
    J Assist Reprod Genet; 1995 Jan; 12(1):8-12. PubMed ID: 7580013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential use of clomiphene citrate, human menopausal gonadotropin, and human chorionic gonadotropin in human in vitro fertilization. II. Study of luteal phase adequacy following aspiration of the preovulatory follicles.
    Cohen JJ; Debache C; Pigeau F; Mandelbaum J; Plachot M; de Brux J
    Fertil Steril; 1984 Sep; 42(3):360-5. PubMed ID: 6432585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of different follicle-stimulating hormone and luteinizing hormone ratios for ovulation induction during in vitro fertilization.
    Tepper R; Tadir Y; Kaplan-Kraicer R; Amit S; Pinkas H; Ovadia J
    Int J Fertil; 1992; 37(6):335-8. PubMed ID: 1360452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.